osimertinib 80 MG Oral Tablet [Tagrisso]
- RxCUI
- 1721583
- RxNorm name
- osimertinib 80 MG Oral Tablet [Tagrisso]
- Display name
- osimertinib 80 MG Oral Tablet [Tagrisso]
- Full name
- osimertinib 80 MG Oral Tablet [Tagrisso]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAGRISSO | OSIMERTINIB | AstraZeneca Pharmaceuticals LP | 5e81b4a7-b971-45e1-9c31-29cea8c87ce7 | 2024-09-25 | Warnings, Adverse reactions | 1721583 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5e81b4a7-b971-45e1-9c31-29cea8c87ce7 | osimertinib 80 MG Oral Tablet [Tagrisso] | SBD | 36 | These highlights do not include all the information needed to use TAGRISSO safely and effectively. See full prescribing information for TAGRISSO. TAGRISSO ® (osimertinib) tablets, for oral use Initial U.S. Approval: 2015 | 20240925 |
| 5e81b4a7-b971-45e1-9c31-29cea8c87ce7 | Tagrisso 80 MG (as osimertinib mesylate 95.4 MG) Oral Tablet | SY | 36 | These highlights do not include all the information needed to use TAGRISSO safely and effectively. See full prescribing information for TAGRISSO. TAGRISSO ® (osimertinib) tablets, for oral use Initial U.S. Approval: 2015 | 20240925 |
| 5e81b4a7-b971-45e1-9c31-29cea8c87ce7 | Tagrisso 80 MG Oral Tablet | PSN | 36 | These highlights do not include all the information needed to use TAGRISSO safely and effectively. See full prescribing information for TAGRISSO. TAGRISSO ® (osimertinib) tablets, for oral use Initial U.S. Approval: 2015 | 20240925 |